Nervgen Pharma Corp. (NGEN)

CIK 1751912 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nervgen Pharma Corp..

Recent SEC filings

FiledFormAccession number
Aug 13, 20266-K0001104659-26-095467
Jul 2, 2026SUPPL0001104659-26-080430
Jul 2, 20266-K0001104659-26-080432
Jun 1, 20266-K0001104659-26-069028
May 26, 2026F-X0001104659-26-066079
May 26, 2026F-100001104659-26-066063
May 26, 2026EFFECT9999999995-26-001763
May 26, 20266-K0001104659-26-066307
May 26, 2026SUPPL0001104659-26-066304
May 22, 2026SUPPL0001104659-26-065817
May 22, 20266-K0001104659-26-065821
May 21, 2026SUPPL0001104659-26-065185
May 18, 20266-K0001104659-26-063212
May 15, 20266-K0001104659-26-062618
May 7, 2026S-80001104659-26-057111
Apr 27, 20266-K0001104659-26-049508
Mar 31, 202640-F0001104659-26-037357
Mar 13, 20266-K0001104659-26-027740
Feb 13, 20266-K0001104659-26-015192
Feb 10, 20266-K0001104659-26-012610
Jan 23, 2026S-80001104659-26-006289
Jan 8, 20266-K0001104659-26-002130
Jan 7, 2026CERT0001354457-26-000019
Jan 7, 2026F-10/A0001104659-26-001741
Jan 7, 20268-A12B0001104659-26-001789